Size (and Structure) Matters
Pharmaceutical Representative
Alan Reicheg, SVP of Qforma, explains how in an era of field force cutbacks, targeting is key.
Read Article
Qforma Technology Helps Predict the Future of Angioplasty
USA Today
"Independent analyses performed at the request of USA TODAY suggest the meteoric rise of angioplasty during the past three decades has ended."
Read the Article
Redefining the Salesforce Landscape
PharmaVOICE Magazine
Kelly Myers, CEO of Qforma, explains how many prominent action leaders in their network are either not targeted or considered low priority targets.
Read Article